TM2D2

gene
On this page

Also known as BLP1

Summary

TM2D2 (TM2 domain containing 2, HGNC:24127) is a protein-coding gene on chromosome 8p11.22, encoding TM2 domain-containing protein 2 (Q9BX73). It is a selective cancer dependency (DepMap: 13.5% of cell lines).

The protein encoded by this gene contains a structural module related to that of the seven transmembrane domain G protein-coupled receptor superfamily. This protein has sequence and structural similarities to the beta-amyloid binding protein (BBP), but, unlike BBP, it does not regulate a response to beta-amyloid peptide. This protein may have regulatory roles in cell death or proliferation signal cascades. This gene has multiple alternatively spliced transcript variants which encode two different isoforms.

Source: NCBI Gene 83877 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 36 total
  • Cancer dependency (DepMap): dependent in 13.5% of screened cell lines
  • MANE Select transcript: NM_078473

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24127
Approved symbolTM2D2
NameTM2 domain containing 2
Location8p11.22
Locus typegene with protein product
StatusApproved
AliasesBLP1
Ensembl geneENSG00000169490
Ensembl biotypeprotein_coding
OMIM610081
Entrez83877

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 8 protein_coding, 2 retained_intron, 2 protein_coding_CDS_not_defined

ENST00000397070, ENST00000456397, ENST00000456845, ENST00000517872, ENST00000519186, ENST00000520152, ENST00000521060, ENST00000522142, ENST00000522434, ENST00000524331, ENST00000912343, ENST00000912344

RefSeq mRNA: 4 — MANE Select: NM_078473 NM_001024380, NM_001024381, NM_031940, NM_078473

CCDS: CCDS43733, CCDS6111

Canonical transcript exons

ENST00000456397 — 4 exons

ExonStartEnd
ENSE000012750413898880838991545
ENSE000021035583899621338996509
ENSE000035198323899354538993660
ENSE000035919753899531838995405

Expression profiles

Bgee: expression breadth ubiquitous, 256 present calls, max score 94.66.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.3298 / max 177.2784, expressed in 1817 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
9277328.32491817
927740.00492

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481994.66gold quality
stromal cell of endometriumCL:000225594.37gold quality
ileal mucosaUBERON:000033194.27gold quality
islet of LangerhansUBERON:000000694.19gold quality
amniotic fluidUBERON:000017394.15gold quality
deciduaUBERON:000245093.79gold quality
pancreatic ductal cellCL:000207993.78gold quality
placentaUBERON:000198793.61gold quality
germinal epithelium of ovaryUBERON:000130493.34gold quality
palpebral conjunctivaUBERON:000181293.33gold quality
spermCL:000001993.22gold quality
gall bladderUBERON:000211092.95gold quality
visceral pleuraUBERON:000240192.76gold quality
corpus epididymisUBERON:000435992.76gold quality
parietal pleuraUBERON:000240092.69gold quality
endothelial cellCL:000011592.68gold quality
monocyteCL:000057692.40gold quality
epithelial cell of pancreasCL:000008392.30gold quality
leukocyteCL:000073892.22gold quality
tibialis anteriorUBERON:000138591.84gold quality
oviduct epitheliumUBERON:000480491.63gold quality
calcaneal tendonUBERON:000370191.62gold quality
adult organismUBERON:000702391.29gold quality
lower lobe of lungUBERON:000894991.24gold quality
left adrenal glandUBERON:000123491.15gold quality
right adrenal gland cortexUBERON:003582791.11gold quality
smooth muscle tissueUBERON:000113591.09gold quality
skin of hipUBERON:000155491.06gold quality
adult mammalian kidneyUBERON:000008290.98gold quality
seminal vesicleUBERON:000099890.96gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-6701yes43.26
E-MTAB-2983no1211.29
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

96 targeting TM2D2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-1252-5P100.0069.802774
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-428299.9975.366408
HSA-MIR-477599.9875.006394
HSA-MIR-56899.9869.862084
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-548AN99.9770.912817
HSA-MIR-590-3P99.9674.346478
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-365899.9673.874379
HSA-MIR-552-5P99.9368.561583
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-17-5P99.8973.832665
HSA-MIR-430299.8967.941187
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-526B-3P99.8874.062587
HSA-MIR-20B-5P99.8874.012621
HSA-MIR-519D-3P99.8873.972607
HSA-MIR-93-5P99.8873.982606
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-449299.8768.253611
HSA-LET-7G-3P99.8570.431929
HSA-MIR-544A99.8468.661965

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 13.5% of screened cell lines.

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriotm2d2ENSDARG00000035515
mus_musculusTm2d2ENSMUSG00000031556
rattus_norvegicusTm2d2ENSRNOG00000016559
drosophila_melanogasteramrtFBGN0030522
caenorhabditis_elegansWBGENE00015353

Paralogs (2): TM2D1 (ENSG00000162604), TM2D3 (ENSG00000184277)

Protein

Protein identifiers

TM2 domain-containing protein 2Q9BX73 (reviewed: Q9BX73)

Alternative names: Beta-amyloid-binding protein-like protein 1

All UniProt accessions (4): E5RIQ5, E5RIT0, E5RJK9, Q9BX73

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Tissue specificity. Widely expressed.

Similarity. Belongs to the TM2 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BX73-11yes
Q9BX73-22

RefSeq proteins (4): NP_001019551, NP_001019552, NP_114146, NP_510882* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007829TM2Domain
IPR050932TM2D1-3-likeFamily

Pfam: PF05154

UniProt features (12 total): topological domain 3, glycosylation site 2, transmembrane region 2, signal peptide 1, chain 1, splice variant 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BX73-F181.630.55

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 92, 37

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 132 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, AHRARNT_01, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, CREBP1_Q2, TGACCTY_ERR1_Q2, BRUECKNER_TARGETS_OF_MIRLET7A3_DN, WEI_MYCN_TARGETS_WITH_E_BOX, TCF4_Q5, GARY_CD5_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, AACTTT_UNKNOWN, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN, TGGAAA_NFAT_Q4_01, TAATTA_CHX10_01

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

416 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TM2D2TM2D1Q9BX74978
TM2D2PLEKHA2Q9HB19620
TM2D2DDHD2O94830582
TM2D2PLPP5Q8NEB5570
TM2D2NHLRC2Q8NBF2566
TM2D2FAM110AQ9BQ89511
TM2D2NSD3Q9BZ95507
TM2D2ERLIN2O94905507
TM2D2ZMAT4Q9H898489
TM2D2PLPBPO94903489
TM2D2HTRA4P83105483
TM2D2LSM1O15116459
TM2D2NPRL2Q8WTW4431
TM2D2TM2D3Q9BRN9429
TM2D2BAG4O95429428

IntAct

9 interactions, top by confidence:

ABTypeScore
GJB2TM2D2psi-mi:“MI:0915”(physical association)0.560
TM2D2TMEM97psi-mi:“MI:0914”(association)0.530
PARP2TM2D2psi-mi:“MI:0557”(adp ribosylation reaction)0.440
TM2D3SPINT1psi-mi:“MI:0914”(association)0.350
MFSD10NDUFS8psi-mi:“MI:0914”(association)0.350
GJB2TM2D2psi-mi:“MI:0915”(physical association)0.000

BioGRID (33): TM2D3 (Affinity Capture-MS), SIDT2 (Affinity Capture-MS), UQCC1 (Affinity Capture-MS), TMEM97 (Affinity Capture-MS), PCNXL3 (Affinity Capture-MS), UQCC2 (Affinity Capture-MS), SLC47A1 (Affinity Capture-MS), MBOAT7 (Affinity Capture-MS), PIGM (Affinity Capture-MS), ALG8 (Affinity Capture-MS), TMEM39A (Affinity Capture-MS), ERGIC2 (Affinity Capture-MS), SGPP1 (Affinity Capture-MS), TM2D2 (Affinity Capture-MS), TM2D2 (Positive Genetic)

ESM2 similar proteins: A0A1B0GRQ0, A0A1B0GVT2, A2RRL7, A3KN25, A4IFL1, G1TZA0, O18968, O54851, O70610, P08033, P0DKX4, P28230, P28234, P28235, P29414, P33725, P35212, P36382, P41987, P56513, Q01231, Q03190, Q08755, Q08EA8, Q0VCR2, Q2TA35, Q3MHM8, Q58CU5, Q5HZE8, Q5M8E3, Q5RCC0, Q60HF7, Q64448, Q6WGK6, Q7TNI2, Q866T7, Q8BSD4, Q8CFA6, Q8N6S5, Q8R0I4

Diamond homologs: A5PLF5, A5PLH4, P61228, Q07FZ2, Q2TA35, Q566R2, Q5M8E3, Q5RCC0, Q5XGR4, Q6DE06, Q6DHN3, Q8BJ83, Q8R0I4, Q95PJ8, Q95QZ5, Q99MB3, Q9BRN9, Q9BX73, Q9BX74, Q9U4H5, Q9VY86, Q9W2H1, Q9GPR3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

36 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance27
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

664 predictions. Top by Δscore:

VariantEffectΔscore
8:38993543:A:ACdonor_gain1.0000
8:38993544:C:CCdonor_gain1.0000
8:38995472:G:Cacceptor_gain1.0000
8:38995477:C:CTacceptor_gain1.0000
8:38996211:A:ACdonor_gain1.0000
8:38996212:C:CCdonor_gain1.0000
8:38993537:ACACT:Adonor_loss0.9900
8:38993538:CACTT:Cdonor_loss0.9900
8:38993539:ACTT:Adonor_loss0.9900
8:38993540:CTTAC:Cdonor_loss0.9900
8:38993541:TT:Tdonor_loss0.9900
8:38993542:TACT:Tdonor_loss0.9900
8:38993543:ACTT:Adonor_loss0.9900
8:38993544:C:Tdonor_loss0.9900
8:38993544:CT:Cdonor_gain0.9900
8:38993544:CTTTA:Cdonor_gain0.9900
8:38993656:CCGAA:Cacceptor_gain0.9900
8:38993657:CGAAC:Cacceptor_gain0.9900
8:38993658:GAAC:Gacceptor_loss0.9900
8:38993659:AAC:Aacceptor_loss0.9900
8:38993660:AC:Aacceptor_loss0.9900
8:38993661:C:CCacceptor_gain0.9900
8:38993661:C:CGacceptor_loss0.9900
8:38993662:T:Aacceptor_loss0.9900
8:38995313:CTCA:Cdonor_loss0.9900
8:38995314:TCAC:Tdonor_loss0.9900
8:38995315:CAC:Cdonor_loss0.9900
8:38995316:A:ATdonor_loss0.9900
8:38995317:C:Adonor_loss0.9900
8:38995471:C:CTacceptor_gain0.9900

AlphaMissense

1371 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:38991347:C:AW210C1.000
8:38991347:C:GW210C1.000
8:38991349:A:GW210R1.000
8:38991349:A:TW210R1.000
8:38991387:A:TL197Q1.000
8:38991396:A:GL194P1.000
8:38991398:G:CD193E1.000
8:38991398:G:TD193E1.000
8:38991399:T:AD193V1.000
8:38991399:T:CD193G1.000
8:38991399:T:GD193A1.000
8:38991400:C:GD193H1.000
8:38991400:C:TD193N1.000
8:38991409:A:GW190R1.000
8:38991409:A:TW190R1.000
8:38991412:A:GW189R1.000
8:38991412:A:TW189R1.000
8:38991417:C:TG187E1.000
8:38991423:C:TG185E1.000
8:38991424:C:GG185R1.000
8:38991424:C:TG185R1.000
8:38991426:C:AG184V1.000
8:38991426:C:TG184E1.000
8:38991427:C:GG184R1.000
8:38991427:C:TG184R1.000
8:38991438:A:GL180P1.000
8:38991440:C:AK179N1.000
8:38991440:C:GK179N1.000
8:38991444:C:TG178E1.000
8:38991473:G:CF168L1.000

dbSNP variants (sampled 300 via entrez): RS1000030858 (8:38993967 GCTTTACTTAT>G), RS1000331919 (8:38996639 C>T), RS1000716955 (8:38996653 T>C), RS1000754451 (8:38992499 AT>A), RS1000984841 (8:38992010 G>C), RS1000987417 (8:38990512 T>C,G), RS1001206948 (8:38996141 T>C), RS1001244347 (8:38993271 T>C), RS1001375936 (8:38998942 T>A,C), RS1001451867 (8:38997419 TC>T,TCC), RS1001654635 (8:38993581 G>A), RS1002331117 (8:38996809 G>A,T), RS1002388535 (8:38997597 G>A,T), RS1002654268 (8:38991776 G>A), RS1002700944 (8:38989285 T>C)

Disease associations

OMIM: gene MIM:610081 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinincreases expression2
Valproic Acidincreases expression2
aristolochic acid Idecreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
sodium arseniteincreases abundance, increases expression1
ferrous chloridedecreases expression1
di-n-butylphosphoric acidaffects expression1
deguelindecreases expression1
2-palmitoylglycerolincreases expression1
Bortezomibincreases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Antimycin Adecreases expression1
Arsenicincreases abundance, increases expression1
Benzeneincreases expression1
Benzo(a)pyreneincreases methylation1
Dimethyl Sulfoxideincreases expression1
Drugs, Chinese Herbalincreases expression1
Naphthoquinonesincreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1decreases methylation1
Copper Sulfateaffects expression1
Acrylamideincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.